Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment

Blaithnead Murtagh, Stuart Higano, Ryan Lennon, Verghese Mathew, David Holmes, Amir Lerman

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Background: The achievement of maximal vasodilatation of the coronary microvessels is mandatory for the accurate determination of fractional flow reserve (FFR); the optimal dosing to achieve maximal vasodilation is unclear. This study was designed to address the hypothesis that incremental doses of intracoronary adenosine are necessary to ensure complete vasodilatation of the coronary microcirculation and accurate assessment of FFR. We also examined the relationship between FFR and coronary artery disease risk factors. Methods: A total of 191 patients (215 vessels) with intermediate coronary lesions were examined. FFR was measured during cardiac catheterization with a pressure monitoring wire. Incremental doses of intracoronary adenosine (12-42 μg, left coronary artery; 12-48 μg, right coronary artery) were administered. Results: Diabetes mellitus was present in 23% of patients, hypertension was present in 65% of patients, and prior myocardial infarction had occurred in 25% of patients. The average percent stenosis in vessels was 57% ± 15%. Vessels were subdivided on the basis of initial FFR (group 1, <0.75; group II, 0.75-0.79; group III, 0.80-0.89; group IV, ≥0.9). Five of the 24 (21%) vessels with an initial FFR in the 0.75 to 0.80 range had a subsequent FFR of <0.75. There was no difference in FFR or doses of adenosine in the patients with coronary artery disease risk factors. The average adenosine dose given at the achievement of minimal FFR was 26 μg in the right coronary artery (RCA) and 34 μg in the left coronary artery (LCA). The average maximum dose of intracoronary adenosine administered was 29 μg for the RCA and 37 μg for the LCA. The maximum dose of adenosine ever required to achieve minimum FFR was 42 μg in both the LCA and RCA. Conclusion: This study suggests that a single high dose of 42 μg of intracoronary adenosine for both the RCA and LCA is sufficient to achieve maximum hyperemia and accurate FFR in most patients, independent of risk factors. Alternatively, when a lower initial dose is administered and FFR is in the 0.75 to 0.90 range, incremental doses of adenosine should be administered to ensure maximal hyperemia.

Original languageEnglish (US)
Pages (from-to)99-105
Number of pages7
JournalAmerican Heart Journal
Volume146
Issue number1
DOIs
StatePublished - Jul 1 2003

Fingerprint

Adenosine
Coronary Vessels
Vasodilation
Hyperemia
Coronary Artery Disease
Microcirculation
Cardiac Catheterization
Microvessels
Diabetes Mellitus
Pathologic Constriction
Myocardial Infarction
Hypertension
Pressure

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. / Murtagh, Blaithnead; Higano, Stuart; Lennon, Ryan; Mathew, Verghese; Holmes, David; Lerman, Amir.

In: American Heart Journal, Vol. 146, No. 1, 01.07.2003, p. 99-105.

Research output: Contribution to journalArticle

Murtagh, Blaithnead ; Higano, Stuart ; Lennon, Ryan ; Mathew, Verghese ; Holmes, David ; Lerman, Amir. / Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment. In: American Heart Journal. 2003 ; Vol. 146, No. 1. pp. 99-105.
@article{1fe10f24bb9b48beae3f08614003dfbc,
title = "Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment",
abstract = "Background: The achievement of maximal vasodilatation of the coronary microvessels is mandatory for the accurate determination of fractional flow reserve (FFR); the optimal dosing to achieve maximal vasodilation is unclear. This study was designed to address the hypothesis that incremental doses of intracoronary adenosine are necessary to ensure complete vasodilatation of the coronary microcirculation and accurate assessment of FFR. We also examined the relationship between FFR and coronary artery disease risk factors. Methods: A total of 191 patients (215 vessels) with intermediate coronary lesions were examined. FFR was measured during cardiac catheterization with a pressure monitoring wire. Incremental doses of intracoronary adenosine (12-42 μg, left coronary artery; 12-48 μg, right coronary artery) were administered. Results: Diabetes mellitus was present in 23{\%} of patients, hypertension was present in 65{\%} of patients, and prior myocardial infarction had occurred in 25{\%} of patients. The average percent stenosis in vessels was 57{\%} ± 15{\%}. Vessels were subdivided on the basis of initial FFR (group 1, <0.75; group II, 0.75-0.79; group III, 0.80-0.89; group IV, ≥0.9). Five of the 24 (21{\%}) vessels with an initial FFR in the 0.75 to 0.80 range had a subsequent FFR of <0.75. There was no difference in FFR or doses of adenosine in the patients with coronary artery disease risk factors. The average adenosine dose given at the achievement of minimal FFR was 26 μg in the right coronary artery (RCA) and 34 μg in the left coronary artery (LCA). The average maximum dose of intracoronary adenosine administered was 29 μg for the RCA and 37 μg for the LCA. The maximum dose of adenosine ever required to achieve minimum FFR was 42 μg in both the LCA and RCA. Conclusion: This study suggests that a single high dose of 42 μg of intracoronary adenosine for both the RCA and LCA is sufficient to achieve maximum hyperemia and accurate FFR in most patients, independent of risk factors. Alternatively, when a lower initial dose is administered and FFR is in the 0.75 to 0.90 range, incremental doses of adenosine should be administered to ensure maximal hyperemia.",
author = "Blaithnead Murtagh and Stuart Higano and Ryan Lennon and Verghese Mathew and David Holmes and Amir Lerman",
year = "2003",
month = "7",
day = "1",
doi = "10.1016/S0002-8703(03)00120-0",
language = "English (US)",
volume = "146",
pages = "99--105",
journal = "American Heart Journal",
issn = "0002-8703",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment

AU - Murtagh, Blaithnead

AU - Higano, Stuart

AU - Lennon, Ryan

AU - Mathew, Verghese

AU - Holmes, David

AU - Lerman, Amir

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: The achievement of maximal vasodilatation of the coronary microvessels is mandatory for the accurate determination of fractional flow reserve (FFR); the optimal dosing to achieve maximal vasodilation is unclear. This study was designed to address the hypothesis that incremental doses of intracoronary adenosine are necessary to ensure complete vasodilatation of the coronary microcirculation and accurate assessment of FFR. We also examined the relationship between FFR and coronary artery disease risk factors. Methods: A total of 191 patients (215 vessels) with intermediate coronary lesions were examined. FFR was measured during cardiac catheterization with a pressure monitoring wire. Incremental doses of intracoronary adenosine (12-42 μg, left coronary artery; 12-48 μg, right coronary artery) were administered. Results: Diabetes mellitus was present in 23% of patients, hypertension was present in 65% of patients, and prior myocardial infarction had occurred in 25% of patients. The average percent stenosis in vessels was 57% ± 15%. Vessels were subdivided on the basis of initial FFR (group 1, <0.75; group II, 0.75-0.79; group III, 0.80-0.89; group IV, ≥0.9). Five of the 24 (21%) vessels with an initial FFR in the 0.75 to 0.80 range had a subsequent FFR of <0.75. There was no difference in FFR or doses of adenosine in the patients with coronary artery disease risk factors. The average adenosine dose given at the achievement of minimal FFR was 26 μg in the right coronary artery (RCA) and 34 μg in the left coronary artery (LCA). The average maximum dose of intracoronary adenosine administered was 29 μg for the RCA and 37 μg for the LCA. The maximum dose of adenosine ever required to achieve minimum FFR was 42 μg in both the LCA and RCA. Conclusion: This study suggests that a single high dose of 42 μg of intracoronary adenosine for both the RCA and LCA is sufficient to achieve maximum hyperemia and accurate FFR in most patients, independent of risk factors. Alternatively, when a lower initial dose is administered and FFR is in the 0.75 to 0.90 range, incremental doses of adenosine should be administered to ensure maximal hyperemia.

AB - Background: The achievement of maximal vasodilatation of the coronary microvessels is mandatory for the accurate determination of fractional flow reserve (FFR); the optimal dosing to achieve maximal vasodilation is unclear. This study was designed to address the hypothesis that incremental doses of intracoronary adenosine are necessary to ensure complete vasodilatation of the coronary microcirculation and accurate assessment of FFR. We also examined the relationship between FFR and coronary artery disease risk factors. Methods: A total of 191 patients (215 vessels) with intermediate coronary lesions were examined. FFR was measured during cardiac catheterization with a pressure monitoring wire. Incremental doses of intracoronary adenosine (12-42 μg, left coronary artery; 12-48 μg, right coronary artery) were administered. Results: Diabetes mellitus was present in 23% of patients, hypertension was present in 65% of patients, and prior myocardial infarction had occurred in 25% of patients. The average percent stenosis in vessels was 57% ± 15%. Vessels were subdivided on the basis of initial FFR (group 1, <0.75; group II, 0.75-0.79; group III, 0.80-0.89; group IV, ≥0.9). Five of the 24 (21%) vessels with an initial FFR in the 0.75 to 0.80 range had a subsequent FFR of <0.75. There was no difference in FFR or doses of adenosine in the patients with coronary artery disease risk factors. The average adenosine dose given at the achievement of minimal FFR was 26 μg in the right coronary artery (RCA) and 34 μg in the left coronary artery (LCA). The average maximum dose of intracoronary adenosine administered was 29 μg for the RCA and 37 μg for the LCA. The maximum dose of adenosine ever required to achieve minimum FFR was 42 μg in both the LCA and RCA. Conclusion: This study suggests that a single high dose of 42 μg of intracoronary adenosine for both the RCA and LCA is sufficient to achieve maximum hyperemia and accurate FFR in most patients, independent of risk factors. Alternatively, when a lower initial dose is administered and FFR is in the 0.75 to 0.90 range, incremental doses of adenosine should be administered to ensure maximal hyperemia.

UR - http://www.scopus.com/inward/record.url?scp=0038160839&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038160839&partnerID=8YFLogxK

U2 - 10.1016/S0002-8703(03)00120-0

DO - 10.1016/S0002-8703(03)00120-0

M3 - Article

C2 - 12851614

AN - SCOPUS:0038160839

VL - 146

SP - 99

EP - 105

JO - American Heart Journal

JF - American Heart Journal

SN - 0002-8703

IS - 1

ER -